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Duration of hospitalization during the first two 
years after AIDS diagnosis: A descriptive study 
Summary 
Has there been a chanqe in the duration of periods of hospitalization 
during the first two years after diagnosis of AIDS between patients 
diagnosed before 1988, compared with patients diagnosed since 1988? 
A cohort of 212 AIDS patients was studied. They were diagnosed before 
December 31, 1990 an d were hospitalized between January t, 1981 and 
March 31, 1993 in the Universi~ Hospital of Geneva, Switzerland. Over- 
all, the duration of hospitalization did not seem to differ according to the 
year of AIDS diagnosis, though the more recently diagnosed patients 
were hospitalized with a more advanced level of immunosuppression. 
However, the pattern of hospitalization was slightly different. The periods 
of hospitalization for subjects diagnosed before 1988 were relatively 
longer soon after the AIDS diagnosis and at a late stage in the course 
of the disease, whereas for the more recent patients the lengths of 
hospital stays were more uniform during the whole course of the 
disease. 
It is still unclear whether improve- 
ments in prophylaxis and medical 
care have reduced the time patients 
spend in hospital after AIDS dia- 
gnosis. Several reports indicate 
that the average duration of hos- 
pitalization of AIDS patients 
has decreased since the beginning 
of the AIDS epidemic 2-4, but insuf- 
ficient attention has been given to 
the possibility of cross-sectional 
bias. This was suggested to us 
when analyzing the results for the 
Geneva component of the Swiss 
HIV cohort study. In a first cross- 
sectional analysis, we found and 
reported a linear decline in cumu- 
lative length of hospitalization of 
AIDS patients between 1981 and 
19905. However, a subsequent ana- 
lysis stratified into cohorts accord- 
ing to year of AIDS diagnosis did 
not confirm the decline. In addi- 
tion, it suggested that the timing 
of hospitalization varied accord- 
ing from cohort to cohort. More 
recently diagnosed AIDS patients 
were hospitalized for shorter pe- 
riods early after diagnosis, but for 
longer periods later on. 
In the present paper we describe 
the duration of hospital stays 
during the two years after diagno- 
sis. We studied the hospital days 
used by AIDS patients rather 
than exploring the hospitalisation 
histories of individual patients 
because we were interested in esti- 
mating the resources provided by 
the institution. We stratified pa- 
tients on the basis of AIDS diagno- 
sis before or after 1988, because 
this was the year of the introduc- 
tion of zidovudine and Pneurno- 
cystis carinii (PCP) prophylaxis. 
We also stratified on duration of 
follow-up, to adjust for the survival 
bias involved in assessing hospital 
stays. All patients were followed 
for at least 6 months after the 
AIDS diagnosis to allow the identi- 




All patients were eligible for the 
present study who 1) met the 1987 
CDC criteria for AIDS 6, 2) were 
hospitalized before December 31, 
1990, for more than one day at 
the University Hospital of Geneva 
(the Canton of Geneva has one 
of the highest incidence rates of 
314 
Soz.- Pr~ventivmed. 1997; 42 :314-319 
AIDS in EuropeT-8). The sample 
of 212 patients represented 83 % of 
all AIDS cases diagnosed uring 
that period in the Canton of 
Geneva according to the data 
of the Geneva Department of Pu- 
blic Health 8. Sociodemographic 
variables (sex, age, risk factors), 
and date of AIDS diagnosis and 
every admission to discharge from 
hospital, were abstracted from 
medical charts and from the Swiss 
HIV cohort study (SHCS) data- 
base using standardized forms. 
The SHCS has been described in 
detail elsewhere 9. Briefly, the co- 
hort comprises all HIV positive 
patients followed in University 
Hospitals in Switzerland. In the 
SCHS, the major risk factor for 
AIDS and the date of initial dia- 
gnosis of AIDS are determined for 
all subjects by their physicians. The 
level of CD4+ T lymphocytes was 
determined as close as possible to 
the time of diagnosis by standard- 
ized methods 10. 
Statistical analysis 
The statistical analysis was restrict- 
ed to subjects followed for 6 
months to 2 years from the day of 
AIDS diagnosis, to the last infor- 
mation date available or death. We 
report he categorical data in a per- 
centage and frequency table, and 
continuous data as means (+_ stan- 
dard deviation). We calculated the 
average of duration of hospital 
stays per semester after the AIDS 
diagnosis, stratified on diagnosis 
before and after 1988. The average 
duration of hospital stays was the 
mean of cumulated ays spent in 
hospital during a given period of 
time, divided by the number of hos- 
pital admissions. The comparisons 
of categorical data were done using 
the chi-squared test, and the com- 
parisons of continuous date were 
assessed by the Mann-Whitney U- 
test or the t-test on logarithmic 
transformations. 
Resu l ts  
In the whole sample (n = 212), the 
mean age was 34.9 years (_+ 9.2 
years), 81% were male, 43 % were 
homosexual or bisexual (HS/BS), 
and 35% were intravenous drug 
users (IVDU). Table i shows that 
there were no significant differen- 
ces in sex, age, and risk factors 
whether AIDS was diagnosed 
before (n=71) or since 1988 
(n = 141). Neither were there sig- 
nificant differences in frequency of 
opportunistic infections. Thirty 
five percent of patients who had 
AIDS before 1988 received zidovu- 
dine, and 71% of those diagnosed 
since 1988 (p=0.001). Patients 
diagnosed since 1988 had lower 
CD4 counts at the time of AIDS 
diagnosis (median = 60/mm 3) than 
patients diagnosed before 1988 
(median 120/mm 3,p <0.0001) (not 
shown in a table). 
Table 2 shows the number of hos- 
pitalizations and their durations by 
semester after AIDS diagnosis, 
stratified on the time of diagnosis. 
In each case the analysis was done 
within a period of time for which 
the patients were known to be ali- 
ve. The results are globally similar, 
but for the patients with a follow- 
up lasting > 18 months, the pattern 
of hospitalization durations differ- 
ed strongly by semester according 
to the period of AIDS diagnosis 
(Figure 1, Figure 2). For the pa- 
tients diagnosed before 1988, short- 
er hospital stays occurred at the 
median period of follow-up. Lengths 
of hospital stays seem to be less 
variable for the recent patients. 
Year o f  A IDS diagnosis  
1981-1990 1981-1987 1988-1990 
n = 212 n = 71 n = 141 
Mean age (mean • SD) 34.9 + 9.7 34.7 _+ 9.9 34.9 +_ 9.7 
Gender (n, %) 
Male 172 (81) 57 (80) 115 (82) 
Female 40 (19) 14 (20) 26 (18) 
Risk factors (n, %) 
Homo/bisexual 92 (43) 31 (44) 61 (43) 
Intravenous drug users 75 (35) 23 (32) 52 (37) 
Heterosexual 23 (11) 7 (t0) 16 (11) 
Others 22 (11) 10 (14) t2 (9) 
AIDS defining dlacnosis (n, %) 
CMV* 20 (9) t3 ,~18) 7 (5) 
PCP** 82 (39) 19 (27) 63 (45) 
Toxoplasmosis encephalitis 30 (14) 8 (4) 22 (16) 
Kaposi sarcoma 42 (20) 15 (21) 27 (19) 
Mycobacteriosis 16 (8) 8 (4) 8 (6) 
HIV-dementia 2 t {10) 9 (4) ] 2 ',9) 
* CMV: retinitis or col tis due to cytomegatowrus 
- PCP: Pneurnocystis carinii pneumonia, 
Table 1, Characteristics of AIDS patients by year of diagnosis, Genevaf 
Switzerland, 1981 - 1990. 
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Year of AIDS 
11987 or  earlier 
1988 or later 
1 2 3 
Semesters after AIDS diagnosis 
Figure 1. Average hospital days per semester for AIDS patients stratified 
on the year of diagnosis for patients followed > 18 months. 
Discussion 
The present analysis of the Geneva 
component of the Swiss HIV co- 
hort study suggests that patients 
diagnosed as having AIDS since 
1988 spent the same amount of 
time in hospital during the first two 
years after diagnosis as those 
diagnosed before 1988. Neverthe- 
less, the distribution of the dura- 
tion of periods of hospitalisation 
varied according to the date of 
diagnosis. 
The present study results seem to 
contradict previous cross-sectional 
analyses of the medial care of 
AIDS patients which have indicat- 
ed a time trend towards less hos- 
pitalization 1-3. Seage et al 1 found 
that US patients admitted during 
the first year of a study remained 
hospitalized on average 3.1 days 
longer than patients admitted 
during the second year of the study. 
According to Markson et al.3, hos- 
pitalization duration of New York 
AIDS patients has steadily declin- 
ed at a rate of one day per year 
since 1984. However, these analy- 
ses may have been confounded by 
a cohort effect, hospitalization in 
more recently diagnosed patients 
being delayed but the overall 
duration not reduced. An English 
report has found, as we do, that the 
average time spent in hospital had 
increased for more recently dia- 
gnosed AIDS patients: it was 26 % 
for the AIDS patients diagnosed 
between 1983 and 1988 and 30% 
for those diagnosed between 1988 
and 1990 (calculation from Table 3 
of ref. 4). 
We can speculate about the pos- 
sible reasons why there is no 
decrease of time spent in hospital 
by the more recently-diagnosed 
patients. The total time of hospita- 
lization stayed the same but pa- 
tients were hospitalized later in the 
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Year of AIDS 
~4'~!! 1987 or earlier 
I 1988 or later 
1 2 3 4 
Semesters after AIDS 
Figure 2. Average hospital days per semester for AIDS patients stratified 
on the year of diagnosis for patients followed > 24 months. 
course of HIV infection, as is 
shown by their lower CD4 counts 
at the time of AIDS diagnosis. 
Thus, preventive measures, uch as 
pentamidine inhalations 11-13 and 
zidovudine administration 14,1s now 
postpone the diagnosis of AIDS 
until immunosnppression is more 
advanced. After diagnosis, the 
mean number of hospital days is 
table for recent patients but a dif- 
ferent pattern emerged for the 
patients diagnosed earlier. The pat- 
tern suggests that patients diagnos- 
ed before 1988 spent longer in hos- 
pital soon after diagnosis, because 
diagnostic and therapeutic proce- 
dures were less codified than they 
are today. As immunosuppres- 
sion progresses, diseases uch as 
disseminated mycobacterial in- 
fections, cachexia and diarrhea, 
AIDS-related dementia, and lym- 
phoma, are less easily managed 
outside the hospital, so that more 
hospitalization is required during 
the second year after diagnosis. 
This effect was more pronounced 
for the patients in the earlier group, 
for whom prophylaxis regimens, 
especially against Pneurnocystis 
carinii pneumonia, encephalitis 
toxoplasmosis and mycobacterial 
infections, were less used. 
A limitation of the present study 
was the lack of information on hos- 
pital service consumption by HIV 
positive patients prior to the dia- 
gnosis of AIDS. The changes in the 
pattern of hospitalization during 
the first two years of AIDS diagno- 
sis that we observed may be related 
to complementary changes during 
the pre-AIDS period. A study 4 
found that the number of hospital 
days spent by HIV positive patients 
without AIDS doubled between 
1986 and 1990. Future studies 
should also analyse the pre-AIDS 
period to clarify fully the impact on 
medical services on time spent in 
hospital by patients infected by 
HIV before AIDS in the era of 
HIV protease inhibitors. Another 
limitation was that the analysis was 
carried out only for patients with a 
follow-up period > 6 months. This 
excluded the patients with severe 
disease who died soon after the 
AIDS diagnosis. 
The pattern of hospitalizations for 
these patients with a poor progno- 
sis would have needed a separate 
analysis. 
A strength of the present study is 
that complete information on hos- 
pitalization during the first two 
years after AIDS diagnosis was 
available for 83 % of all AIDS pa- 
tients diagnosed in the Canton of 
Geneva between 1981 and 1990. 
Detailed information on every 
hospitalization episode allowed us 
to compute crude descriptive sta- 
tistics of hospital stay according to 
the duration of follow-up. Finally, 
the analysis was performed for 
AIDS cohorts according to year of 
diagnosis. Even though the pa- 
tients analysed in the present study 
were diagnosed before December 
31, 1990, and the follow-up ended 
in March 1993, it is reasonable to 
believe that these results remain 
valid for recently diagnosed AIDS 
patients ince there has not been a 
change in patients care since 1993 
as profound as that of 1988. 
In summary, improvement in 
AIDS prophylaxis and therapy 
may have delayed the beginning 
major periods of hospitalization 
after diagnosis, but they have not 
reduced the overall time spent hos- 
pitalized during the first two years 
after diagnosis. These findings 
may be at odds with current beliefs 
on the evolution of time spent 
hospitalized by AIDS patients, but 
they deserve to be considered 
seriously, since they could have 
important implications for the evo- 
lution of hospital needs and costs 
related to the AIDS epidemic. 
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